A six-month periodic fasting reduces microalbuminuria and improves metabolic control in patients with type 2 diabetes and diabetic nephropathy: a randomized controlled study
View ORCID ProfileAlba Sulaj, Stefan Kopf, Ekaterina von Rauchhaupt, Elisabeth Kliemank, Maik Brune, Zoltan Kender, Hannelore Bartl, Fabiola Garcia Cortizo, Katarina Klepac, View ORCID ProfileZhe Han, Varun Kumar, Valter Longo, View ORCID ProfileAurelio Teleman, Jürgen G. Okun, View ORCID ProfileJakob Morgenstern, Thomas Fleming, Julia Szendroedi, Stephan Herzig, Peter P. Nawroth
doi: https://doi.org/10.1101/2021.12.01.21266958
Alba Sulaj
1Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1); Heidelberg University Hospital; Heidelberg 69120; Germany
2German Center of Diabetes Research (DZD); Neuherberg 85764; Germany
Stefan Kopf
1Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1); Heidelberg University Hospital; Heidelberg 69120; Germany
2German Center of Diabetes Research (DZD); Neuherberg 85764; Germany
Ekaterina von Rauchhaupt
1Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1); Heidelberg University Hospital; Heidelberg 69120; Germany
2German Center of Diabetes Research (DZD); Neuherberg 85764; Germany
Elisabeth Kliemank
1Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1); Heidelberg University Hospital; Heidelberg 69120; Germany
2German Center of Diabetes Research (DZD); Neuherberg 85764; Germany
Maik Brune
1Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1); Heidelberg University Hospital; Heidelberg 69120; Germany
3Joint Heidelberg-IDC Translational Diabetes Program, Helmholtz Center Munich; Neuherberg, 85764; Germany
Zoltan Kender
1Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1); Heidelberg University Hospital; Heidelberg 69120; Germany
2German Center of Diabetes Research (DZD); Neuherberg 85764; Germany
Hannelore Bartl
1Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1); Heidelberg University Hospital; Heidelberg 69120; Germany
Fabiola Garcia Cortizo
4German Cancer Research Center (DKFZ), Division of Signal Transduction in Cancer and Metabolism, Heidelberg 69120; Germany
Katarina Klepac
5Institute for Diabetes and Cancer; Helmholtz Center Munich; Neuherberg, 85764; Germany
Zhe Han
1Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1); Heidelberg University Hospital; Heidelberg 69120; Germany
Varun Kumar
1Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1); Heidelberg University Hospital; Heidelberg 69120; Germany
Valter Longo
6Longevity Institute, School of Gerontology, and Department of Biological Sciences, University of Southern California; Los Angeles, CA 90089-0191; USA
7FIRC Institute of Molecular Oncology, Italian Foundation for Cancer Research Institute of Molecular Oncology; 20139 Milan; Italy
Aurelio Teleman
4German Cancer Research Center (DKFZ), Division of Signal Transduction in Cancer and Metabolism, Heidelberg 69120; Germany
Jürgen G. Okun
8Department of General Pediatrics, Division of Neuropediatrics and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine; University Hospital Heidelberg; Heidelberg 69120; Germany
Jakob Morgenstern
1Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1); Heidelberg University Hospital; Heidelberg 69120; Germany
2German Center of Diabetes Research (DZD); Neuherberg 85764; Germany
Thomas Fleming
1Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1); Heidelberg University Hospital; Heidelberg 69120; Germany
2German Center of Diabetes Research (DZD); Neuherberg 85764; Germany
Julia Szendroedi
1Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1); Heidelberg University Hospital; Heidelberg 69120; Germany
2German Center of Diabetes Research (DZD); Neuherberg 85764; Germany
3Joint Heidelberg-IDC Translational Diabetes Program, Helmholtz Center Munich; Neuherberg, 85764; Germany
Stephan Herzig
2German Center of Diabetes Research (DZD); Neuherberg 85764; Germany
5Institute for Diabetes and Cancer; Helmholtz Center Munich; Neuherberg, 85764; Germany
9Joint Heidelberg-IDC Translational Diabetes Program, Internal Medicine 1; Heidelberg University Hospital; Heidelberg; 69120; Germany
10Chair Molecular Metabolic Control; Technical University Munich; Munich; 80333; Germany
Peter P. Nawroth
1Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1); Heidelberg University Hospital; Heidelberg 69120; Germany
2German Center of Diabetes Research (DZD); Neuherberg 85764; Germany
3Joint Heidelberg-IDC Translational Diabetes Program, Helmholtz Center Munich; Neuherberg, 85764; Germany
Data Availability
The data generated in this study are subject to national data protection laws and are available from the corresponding author upon reasonable request.
Posted December 05, 2021.
A six-month periodic fasting reduces microalbuminuria and improves metabolic control in patients with type 2 diabetes and diabetic nephropathy: a randomized controlled study
Alba Sulaj, Stefan Kopf, Ekaterina von Rauchhaupt, Elisabeth Kliemank, Maik Brune, Zoltan Kender, Hannelore Bartl, Fabiola Garcia Cortizo, Katarina Klepac, Zhe Han, Varun Kumar, Valter Longo, Aurelio Teleman, Jürgen G. Okun, Jakob Morgenstern, Thomas Fleming, Julia Szendroedi, Stephan Herzig, Peter P. Nawroth
medRxiv 2021.12.01.21266958; doi: https://doi.org/10.1101/2021.12.01.21266958
A six-month periodic fasting reduces microalbuminuria and improves metabolic control in patients with type 2 diabetes and diabetic nephropathy: a randomized controlled study
Alba Sulaj, Stefan Kopf, Ekaterina von Rauchhaupt, Elisabeth Kliemank, Maik Brune, Zoltan Kender, Hannelore Bartl, Fabiola Garcia Cortizo, Katarina Klepac, Zhe Han, Varun Kumar, Valter Longo, Aurelio Teleman, Jürgen G. Okun, Jakob Morgenstern, Thomas Fleming, Julia Szendroedi, Stephan Herzig, Peter P. Nawroth
medRxiv 2021.12.01.21266958; doi: https://doi.org/10.1101/2021.12.01.21266958
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2923)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12719)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4571)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2913)
- Health Policy (1069)
- Hematology (387)
- HIV/AIDS (923)
- Medical Education (423)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4341)
- Nursing (235)
- Nutrition (637)
- Oncology (2264)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6923)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (384)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (179)